# An Immunogenic Personal Neoantigen Vaccine for Cancer Treatment

> **NCT04087252** · PHASE1 · UNKNOWN · sponsor: **Henan Cancer Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Cancer

## Interventions

- **BIOLOGICAL:** tumor neoantigen

## Key facts

- **NCT ID:** NCT04087252
- **Lead sponsor:** Henan Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-04
- **Primary completion:** 2021-10-30
- **Final completion:** 2021-12-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2020-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04087252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04087252, "An Immunogenic Personal Neoantigen Vaccine for Cancer Treatment". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04087252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*